Wolfgang Wostl

821 total citations
9 papers, 545 citations indexed

About

Wolfgang Wostl is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Wolfgang Wostl has authored 9 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Cardiology and Cardiovascular Medicine and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Wolfgang Wostl's work include Renin-Angiotensin System Studies (4 papers), Receptor Mechanisms and Signaling (3 papers) and Hormonal Regulation and Hypertension (3 papers). Wolfgang Wostl is often cited by papers focused on Renin-Angiotensin System Studies (4 papers), Receptor Mechanisms and Signaling (3 papers) and Hormonal Regulation and Hypertension (3 papers). Wolfgang Wostl collaborates with scholars based in Switzerland, Italy and France. Wolfgang Wostl's co-authors include Walter Fischli, Heinz Stadler, Volker Breu, Alfred Binggeli, Marcel Müller, Georges Hirth, Jean‐Paul Clozel, Daniel Bur, Rolf Güller and Christian Oefner and has published in prestigious journals such as Hypertension, British Journal of Cancer and Bioorganic & Medicinal Chemistry.

In The Last Decade

Wolfgang Wostl

9 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wolfgang Wostl Switzerland 9 279 193 138 122 106 9 545
Terry W. Schorn United States 14 531 1.9× 319 1.7× 283 2.1× 149 1.2× 88 0.8× 25 842
John S. Major United Kingdom 13 282 1.0× 84 0.4× 163 1.2× 40 0.3× 58 0.5× 27 578
Debra L. Ondeyka United States 7 232 0.8× 185 1.0× 120 0.9× 80 0.7× 22 0.2× 9 443
Joseph B. Santella United States 11 312 1.1× 92 0.5× 567 4.1× 35 0.3× 75 0.7× 19 901
Matthias Goebel Germany 15 270 1.0× 131 0.7× 201 1.5× 96 0.8× 16 0.2× 22 527
Dennis Colussi United States 20 328 1.2× 124 0.6× 236 1.7× 13 0.1× 214 2.0× 44 827
Yumi Sakane Switzerland 12 222 0.8× 199 1.0× 129 0.9× 85 0.7× 17 0.2× 22 572
Christopher L. Heran United States 14 121 0.4× 162 0.8× 48 0.3× 16 0.1× 27 0.3× 22 503
Roger P. Dickinson United Kingdom 15 215 0.8× 83 0.4× 266 1.9× 16 0.1× 33 0.3× 26 636
Elizabeth M. Naylor United States 11 152 0.5× 74 0.4× 136 1.0× 27 0.2× 23 0.2× 16 320

Countries citing papers authored by Wolfgang Wostl

Since Specialization
Citations

This map shows the geographic impact of Wolfgang Wostl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Wostl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Wostl more than expected).

Fields of papers citing papers by Wolfgang Wostl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang Wostl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Wostl. The network helps show where Wolfgang Wostl may publish in the future.

Co-authorship network of co-authors of Wolfgang Wostl

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang Wostl. A scholar is included among the top collaborators of Wolfgang Wostl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang Wostl. Wolfgang Wostl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Woltering, Thomas J., Wolfgang Wostl, Hans Hilpert, et al.. (2013). BACE1 inhibitors: A head group scan on a series of amides. Bioorganic & Medicinal Chemistry Letters. 23(14). 4239–4243. 43 indexed citations
2.
Kitas, Eric, Guido Galley, Roland Jakob‐Roetne, et al.. (2007). Substituted 2-oxo-azepane derivatives are potent, orally active γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(1). 304–308. 17 indexed citations
3.
Juillerat‐Jeanneret, Lucienne, Jérôme Célérier, Catherine Chapuis Bernasconi, et al.. (2004). Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma. British Journal of Cancer. 90(5). 1059–1068. 120 indexed citations
4.
Vieira, Eric, Alfred Binggeli, Volker Breu, et al.. (1999). Substituted piperidines - highly potent renin inhibitors due to induced fit adaptation of the active site. Bioorganic & Medicinal Chemistry Letters. 9(10). 1397–1402. 79 indexed citations
5.
Güller, Rolf, Alfred Binggeli, Volker Breu, et al.. (1999). Piperidine-renin inhibitors compounds with improved physicochemical properties. Bioorganic & Medicinal Chemistry Letters. 9(10). 1403–1408. 52 indexed citations
6.
Oefner, Christian, Alfred Binggeli, Volker Breu, et al.. (1999). Renin inhibition by substituted piperidines: A novel paradigm for the inhibition of monomeric aspartic proteinases?. Chemistry & Biology. 6(3). 127–131. 100 indexed citations
7.
Estermann, Heinrich, et al.. (1994). Large scale preparation of chiral building blocks for the P3 site of renin inhibitors. Bioorganic & Medicinal Chemistry. 2(6). 403–410. 32 indexed citations
8.
Fischli, Walter, Jean‐Paul Clozel, Volker Breu, et al.. (1994). Ciprokiren (Ro 44-9375). A renin inhibitor with increasing effects on chronic treatment.. Hypertension. 24(2). 163–169. 20 indexed citations
9.
Fischli, Walter, et al.. (1991). Ro 42-5892 is a potent orally active renin inhibitor in primates.. Hypertension. 18(1). 22–31. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026